Tech Company Financing Transactions
Prelude Fertility Funding Round
On 10/18/2016, Prelude Fertility raised $200 million in funding from CapitalG, Index Ventures and Sequoia Capital.
Transaction Overview
Company Name
Announced On
10/18/2016
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Undisclosed
Proceeds Purpose
Armed with $200 million, Prelude plans to take the technology of infertility--in vitro fertilization and egg freezing--and aggressively expand it into fertility, hoping to usher in a world where women's decisions about family and career aren't ruled by their biological clocks.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Atlanta, GA 30342
USA
Atlanta, GA 30342
USA
Phone
Undisclosed
Website
Email Address
Overview
Prelude, a leader in reproductive science and technology, helps people have healthy babies when they're ready. Whether you're just getting started in life or have been at it awhile, if you're not ready today but might be someday, if the family you want is different than the family you came from, you now have options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Martin Varsavsky
Chief Executive Officer
Susan Hertzberg
Chief Financial Officer
Kim Bracuti
VP - Bus. Development
Alexander Saltzman
VP - Operations
Leigh Herzog
VP - Operations
Carly Stockdale
Browse more venture capital transactions:
Prev: 10/18/2016: Veritas Genetics venture capital transaction
Next: 10/18/2016: Snapsheet venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs